Regulatory & Payer Submissions

Regulatory & Payer Submissions

  • Market Access Consulting Brochure

    Market Access Consulting Brochure

    View Now
  • Three ways to power up your real-world evidence portfolio with a registry

    Three ways to power up your real-world evidence portfolio with a registry

    View Now
  • Plan & Engage Early To Manage the Risks of Risk Management

    Plan & Engage Early To Manage the Risks of Risk Management

    View Now
  • See how our experts can add value to your strategy

    Learn More ►
  • Use Real-World Evidence to Navigate From Regulatory Approval to Reimbursement Success

    Use Real-World Evidence to Navigate From Regulatory Approval to Reimbursement Success

    Use Real-World Evidence to Navigate From Regulatory Approval to Reimbursement Success

    View Now
  • Explore the latest updates in Pricing & Reimbursement

    Click Here
  • Integrating Expertise For Product Success

    Integrating Expertise For Product Success

    Creating aligned and integrated physician and payer-focused value propositions

    View Now
  • What Makes a Good Evidence Generation Plan?

    What Makes a Good Evidence Generation Plan?

    This article will introduce some of the key factors and considerations for a successful evidence generation plan with further articles presenting additional details on specific components of the EGP.

    View Now
  • Get your free evidence readiness score today!

    Take Assessment
  • Biosimilar mAbs – a unique and distinct market (for the time being…?)

    Biosimilar mAbs – a unique and distinct market (for the time being…?)

    Read More
  • Real-World Data's Impact on Clinical Research4:29

    Real-World Data's Impact on Clinical Research

    Integrating Real-World Data into clinical research is revolutionizing the life sciences industry. Learn more in this portion of 'The Innovation Imperative: The Future of Drug Development,' an independ

    Watch Video
  • ×

    Speak to one of our experts today

    First Name
    Last Name
    Company Name
    Title
    Country
    Tell us how we can help
    We'll be in touch shortly!
    Error - something went wrong!
  • Navigating Global Regulatory Submissions3:00

    Navigating Global Regulatory Submissions

    Watch Video
  • Parexel Analyzes the Real-World Data Revolution and Role of Early Payer Engagement2:21

    Parexel Analyzes the Real-World Data Revolution and Role of Early Payer Engagement

    Richard Tolley, Vice President Integrated Market Access Solutions at Parexel discusses a recent roundtable discussion about the role of early payer insights in real-world data studies.

    Watch Video
  • Orphan Diseases Translating Expedited Regulatory approval into Reimbursement success article

    Orphan Diseases Translating Expedited Regulatory approval into Reimbursement success article

    View Now
  • Strengthen Your Product Value Story One Phase At A Time

    Strengthen Your Product Value Story One Phase At A Time

    Find out how to plan evidence generation for your value story!

    View Now
  • Innovative trial design Health Economics Webinar PPT

    Innovative trial design Health Economics Webinar PPT

    View Now
  • 4 Ways to Align Real-World Data & Stakeholder Needs

    4 Ways to Align Real-World Data & Stakeholder Needs

    Read More
  • ×

    Tell Us About Your Market Access Nightmares.

    What keeps you up at night?
    Thank you!
    Error - something went wrong!
  • Innovative Clinical Trial Designs — Welcomed By Regulators But What About The Payers?

    Innovative Clinical Trial Designs — Welcomed By Regulators But What About The Payers?

    View Now
  • Presentation Slides: Early Engagement Strategies Webinar

    Presentation Slides: Early Engagement Strategies Webinar

    View Now
  • Promoting the patient voice in evidence generation and global market-access planning

    Promoting the patient voice in evidence generation and global market-access planning

    Presentation from the Medical Affairs Leaders Forum, London. February 27 - March 01, 2018

    View Now
  • The UK Early Access to Medicines Scheme: A 2-Year Status Update On Success, Issues and Controversies

    The UK Early Access to Medicines Scheme: A 2-Year Status Update On Success, Issues and Controversies

    Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

    Read More
  • Could AMNOG Become Irrelevant in the 21st Century? Potential Redundancies in the AMNOG Process in the Era of Curative Therapies

    Could AMNOG Become Irrelevant in the 21st Century? Potential Redundancies in the AMNOG Process in the Era of Curative Therapies

    Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

    Read More
  • loading
    Loading More...